Tumor progression is associated with increasing CD11b+ Cells and CCL2 in Lewis rat sarcoma

Anticancer Research

Volumn 35, Issue 2, 2015, Pages 703-711

  Mishra, Rajbardhan ^a,b   Kovalska, Jana ^a,b   Janda, Jozef ^a   Vannucci, Luca ^a,c   Rajmon, Radko ^b   Horak, Vratislav ^a  

^a INSTITUTE OF ANIMAL PHYSIOLOGY AND GENETICS   (Czech Republic)

^b CZECH UNIVERSITY OF LIFE SCIENCES PRAGUE   (Czech Republic)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

CCL2; CD11b+ cells; Lewis rat sarcoma; Neutrophils; Tumor immunology

Indexed keywords

CCL2 PROTEIN, RAT; CD11B ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL; BLOOD; DISEASE COURSE; EXPERIMENTAL SARCOMA; FLOW CYTOMETRY; LEUKOCYTOSIS; LEWIS RAT; PATHOLOGY; RAT;

ANIMALS; ANTIGENS, CD11B; CHEMOKINE CCL2; DISEASE PROGRESSION; FLOW CYTOMETRY; LEUKOCYTOSIS; RATS; RATS, INBRED LEW; SARCOMA, EXPERIMENTAL;

EID: 84923690572     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Okamoto R, Ueno M, Yamada Y, Takahashi N, Sano H, Suda T and Takakura N: Hematopoietic cells regulate the angiogenic switch during tumorigenesis. Blood 7: 2757-2763, 2005.
2. De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M and Naldini L: Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 3: 211-226, 2005.
3. Nozawa H, Chiu C and Hanahan D: Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 33: 12493-12498, 2006.
4. Takakura N: Role of hematopoietic lineage cells as accessory components in blood vessel formation. Cancer Sci 7: 568-574, 2006.
5. Prado-García H, Avila-Moreno F and López-González JS: Cytotoxic T-lymphocytes in cancer and autoimmunity. Rev Invest Clin 5: 629-939, 2004.
6. Caserta S, Borger JG and Zamoyska R: Central and effector memory CD4 and CD8 T-cell responses to tumor-associated antigens. Crit Rev Immunol 2: 97-126, 2012.
7. Lakshmi Narendra B, Eshvendar Reddy K, Shantikumar S and Ramakrishna S: Immune system: a double-edged sword in cancer. Inflamm Res 9: 823-834, 2013.
8. Toomer KH and Chen Z: Autoimmunity as a double agent in tumor killing and cancer promotion. Front Immunol 5: 116, 2014.
9. Conti I and Rollins BJ: CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol 3: 149-154, 2004.
10. Deshmane SL, Kremlev S, Amini S and Sawaya BE: Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 6: 313-326, 2009.
11. Nakasone Y, Fujimoto M, Matsushita T, Hamaguchi Y, Huu DL, Yanaba M, Sato S, Takehara K and Hasegawa M: Host-derived MCP-1 and MIP-1α regulate protective antitumor immunity to localized and metastatic B16 melanoma. Am J Pathol 1: 365-374, 2012.
12. Yamada M, Yanaba K, Takehara K and Sato S: Clinical significance of serum levels of soluble intercellular adhesion molecule-1 and soluble L-selectin in malignant melanoma. Arch Dermatol Res 6: 256-260, 2005.
13. Dymicka-Piekarska V, Guzinska-Ustymowicz K, Kuklinski A and Kemona H: Prognostic significance of adhesion molecules (sICAM-1, sVCAM-1) and VEGF in colorectal cancer patients. Thromb Res 4: 47-50, 2012.
14. Morávková A, Málek O, Pokorná E, Strnádel J, Hradecký, J and Horák V: Immune characterization of Lewis rats inoculated with K2 sarcoma cell line and newly derived R5-28 malignant cells. Folia Biol-Prague 6: 159-165, 2005.
15. Strnádel J, Kverka M, Horák V, Vannucci L, Usvald D, HlučilováJ, Plánská D, Váňa P, Reisnerová H, and Jílek F: Multiplex analysis of cytokines involved in tumour growth and spontaneous regression in a rat sarcoma model. Folia Biol-Prague 6: 216-219, 2007.
16. Holubova M, Leba M, Sedmikova M, Vannucci L and Horak V: Characterization of three newly established rat sarcoma cell clones. In Vitro Cell Dev Biol Animal 10: 610-618, 2012.
17. Euhus DM, Hudd C, LaRegina MC and Johnson FE: Tumor measurement in the nude mouse. J Surg Oncol 4: 229-234, 1986.
18. Brandau S, Moses K and Lang S: The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: Cousins, siblings or twins? Semin Cancer Biol 23: 171-182, 2013.
19. Gregory AD and Houghton AM: Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res 7: 2411-2416, 2011.
20. Cools-Lartigue J, Spicer J, Najmeh S and Ferri L: Neutrophil extracellular traps in cancer progression. Cell Mol Life Sci 21: 4179-4194, 2014.
21. Lee HW, Choi HJ, Ha SJ, Lee KT and Kwon YG: Recruitment of monocytes/macrophages in different tumor microenvironments. Biochim Biophys Acta 2: 170-179, 2013.
22. + myeloid cells in hypoxic microenvironment of HNSCC. Neoplasia 2: 168-179, 2014.
23. Gong Y and Koh DR: Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model. Cell Tissue Res 2: 437-448, 2010.
24. López-Lago MA, Posner S, Thodima VJ, Molina AM, Motzer RJ and Chaganti RS: Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Oncogene 14: 1752-1760, 2013.
25. Zollo M, Di Dato V, Spano D, De Martino D, Liguori L, Marino N, Vastolo V, Navas L, Garrone B, Mangano G, Biondi G and Guglielmotti A: Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models. Clin Exp Metastasis 6: 585-601, 2012.
26. Boelte KC, Gordy LE, Joyce S, Thompson MA, Yang L and Lin PC: Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1. PLoS One 6: e18534. doi: 10.1371/journal.pone.0018534, 2011.
27. Wang S, Xu M, Li F, Wang X, Bower KA, Frank JA, Lu Y, Chen G, Zhang Z, Ke Z, Shi X and Luo J: Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1. Breast Cancer Res Treat 3: 1037-1048, 2012.
28. Arendt LM, McCready J, Keller PJ, Baker DD, Naber SP, Seewaldt V and Kuperwasser C: Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis. Cancer Res 19: 6080-6093, 2013.
29. + peripheral blood mononuclear cells and induce M2-type macrophage polarization. J Biol Chem 49: 34342-34354, 2009.
30. deSchoolmeester ML, Little MC, Rollins BJ and Else KJ: Absence of CC chemokine ligand 2 results in an altered Th1/Th2 cytokine balance and failure to expel Trichuris muris infection. J Immunol 9: 4693-4700, 2003.
31. van Kilsdonk JW, van Kempen LC, van Muijen GN, Ruiter DJ and Swart GW: Soluble adhesion molecules in human cancers: sources and fates. Eur J Cell Biol 6: 415-427, 2010.
32. Haznedaroglu IC, Benekli M, Ozcebe O, Savaş MC, Güllü IH, Dündar SV and Kirazli S: Serum L-selectin and P-selectin levels in lymphomas. Haematologia (Budap) 1: 27-30, 2000.
33. Liu CM, Sheen TS, Ko JY and Shun CT: Circulating intercellular adhesion molecule 1 (ICAM-1), E-selectin and vascular cell adhesion molecule 1 (VCAM-1) in head and neck cancer. Br J Cancer 2: 360-362, 1999.
34. + T-cells in patients with melanoma. J Immunol 9: 6169-6176, 2005.
35. +) T-cells in a patient with malignant melanoma ascites. Cancer Immunol Immunother 10: 1185-1197, 2006.
36. + T-lymphocytes in human non-small cell lung cancer. Cell Mol Immunol 5: 389-395, 2010.
37. + T-cells are compromised in human pancreatic cancer. Transl Med 2: 105. doi:10.4172/2161-1025.1000105, 2012.
38. van de Berg PJ, van Leeuwen EM, ten Berge IJ and van Lier R: Cytotoxic human CD4(+) T-cells. Curr Opin Immunol 3: 339-343, 2008.
39. Melief CJ: "License to kill" reflects joint action of CD4 and CD8 T-cells. Clin Cancer Res 16: 4295-4296, 2013.
40. Haabeth OA, Tveita AA, Fauskanger M, Schjesvold F, Lorvik KB, Hofgaard PO, Omholt H, Munthe LA, Dembic Z, Corthay A and Bogen B: How do CD4(+) T-cells detect and eliminate tumor cells that either lack or express MHC class II molecules? Front Immunol 5:174, 2014.